Luigi Mangione's ‘manifesto' reveals reason for targeting UnitedHealthcare CEO Brian Thompson, failed plot for mass casualty event: court docs
The deranged 'manifesto' of Luigi Mangione revealed the image-obsessed accused killer chose to 'wack the CEO' of UnitedHealthcare during an investor conference in New York City to generate 'headlines' — and had previously planned a bombing 'catastrophe,' court documents revealed.
Parts of Mangione's scrawlings in red-spiral notebooks were revealed as part of a filing from Manhattan District Attorney Alvin Bragg Wednesday, giving insight into the thought process of the 27-year-old who allegedly targeted Brian Thompson, 50, on Dec. 4, 2024, to prove a political point about the health insurance industry which he wrote 'extracts human life force for money.'
'So say you want to rebel against the deadly, greed fueled health insurance cartel. Do you bomb the HQ? No. Bombs=terrorism,' Mangione wrote in the notebook, which he had in his backpack when he was arrested five days after he allegedly shot the exec in the back on a Midtown street.
Instead, one should 'wack [sic] the CEO at the annual parasitic bean-counter convention. It's targeted and precise and doesn't risk innocents,' Mangione reasoned on Oct. 22, just six weeks before the cold-blooded slaying.
Elsewhere in the manifesto, Mangione wrote that UnitedHealthcare and other insurance providers were justifiable targets because the company 'literally extracts human life force for money.'
The mad screeds further revealed that the University of Pennsylvania graduate had apparently planned a mass-casualty event that could have included a bomb — expressing relief that he had not followed through on the atrocity.
'I'm glad — in a way — that I've procrastinated because it allowed me to learn more about UHC.'
'In MD would've been an unjustified catastrophe that would be perceived mostly as sick, but more importantly unhelpful,' Magione wrote of a potential attack in his native Maryland.
It is not clear what exactly Mangione had planned, but he insinuated that 'innocents' would have been killed.
The reason the 'model prisoner' of his Brooklyn lockup targeted Thompson was 'self-evident,' he wrote.
'The point is made in the news headline Insurance CEO killed at annual investors conference,' Mangione wrote. 'It conveys a greedy bastard that had it coming.
'Members of the public can focus on greed, on the event through reasonable acceptable discussion,' he said of the public reception the apparently planned murder would receive.
Mangione was preoccupied with having action be morally palatable and understood by 'normies' — expressing repeated concern for the public response the murder would receive, even going so far as to analyze potential financial fallout for UnitedHealthcare.
'Finally, the hit is a real low blow to the company financials. All those analysts and institutional investors who came to be wooed by insurance execs? That opportunity is snuffed in an instant,' the accused assassin wrote.
In the same batch of writings, Mangione leveled both praise and criticism on the Unabomber Ted Kaczynski, whom he believed failed to properly communicate his politics to 'normies.'
'For example, Ted K makes some good points on the future of humanity, but to make his point he indiscriminately mailbombs innocents. Normies categorize him as an insane serial killer, focus on the act/atrocities themselves, and dismiss his ideas,' Magione wrote.
Wednesday's filing also included the note Mangione had on his person when he was arrested by police officers in Altoona, Pennsylvania just days after the vicious slaying.
'To the Feds, I'll keep this short because I do respect what you do for our country. To save you a lengthy investigation, I state plainly I wasn't working with anyone. This was fairly trivial, some elementary social engineering, basic [Computer Aided Design], and a lot of patience,' Magione wrote.
'The spiral notebook, if present, has some straggling notes and TODO lists that illuminate the gist of it,' he wrote.
'I do apologize for any strife or trauma, but it had to be done. Frankly, these parasites simply had it coming.'
The note further blathered about the state of health care in the United States and the industry's capitalistic motivations.
Prosecutors argue that these mad, narcissistic ramblings stand up their claim that Mangione's murder was an act of terrorism.
'The shooting itself speaks volumes of the defendant's intent. Defendant chose to shoot the CEO of the United States' largest health insurance company in front of the hotel where the company was about to conduct its annual investor conference,' Bragg wrote in the filing.
Mangione's goal in assassinating Thompson was 'to send a message' which was underscored by the messages the accused allegedly left on the bullet casings ,'Deny,' 'Depose,' and 'Delay,' in reference to the book 'An American Sickness,' prosecutors alleged in the filing.
'If ever there were an open and shut case pointing to a defendant's guilt, this case is that case. Simply put, one would be hard pressed to find a case with such overwhelming evidence of guilty as to the identity of the murderer and the premeditated nature of the assassination,' prosecutors wrote in Wednesday's filing.
Lawyers for Mangione filed to have the writings, found in Mangione's backpack when the then fugitive was picked up in a Pennsylvania McDonald's, excluded from the court record on grounds that he was not afforded his constitutional rights at the time of his arrest.
Prosecutors agreed to hold pre-trial hearings on the admissibility of evidence, including the red spiral notebook and statements he made to police officers at the time of the arrest, the filing stated.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
McCormick brings praise for Philly Mayor Parker, optimism about 'Big Beautiful Bill,' U.S. Steel
U.S. Sen. Dave McCormick (R-Pa.) touring University of Pennsylvania's Marshak Dairy barn in Kennett Square, Pennsylvania on June 6, 2025. (John Cole/Capital-Star) KENNETT SQUARE — Following his tour of Pennsylvania's only veterinary school, U.S. Sen. Dave McCormick (R-Pa.) spoke to the Capital-Star about the U.S. House narrowly passing the 'Big Beautiful Bill' and U.S. Steel's impending merger. But he also had praise for Democratic Philadelphia Mayor Cherelle Parker's efforts to combat addiction in the state's largest city. 'I was very impressed with what the mayor is doing,' McCormick said about Parker's initiative to address addiction, following his tour of the University of Pennsylvania's Marshak Dairy barn in Chester County on the outermost fringes of the Philly suburbs. McCormick said he met earlier Friday with Parker to tour Riverview Wellness Village, a substance abuse recovery center in northeast Philadelphia that aims to help people in the final stages of recovery. According to Billy Penn, the facility, which opened in January, has 336 beds and will provide housing, healthcare, job counseling and other services to people who have completed an initial drug treatment program and have moved to the next stage of their recovery and may live there for up to one year. They already have over 100 patients there, McCormick said. He described the campus of the recovery center, which is built in renovated city-owned buildings, and spans approximately 19 acres along the Delaware River, as 'incredible.' 'This is a facility that gives people dignity, respect and helps them to the next phase,' McCormick said. 'It's a big project for the mayor.' He said he discussed with Parker ways he may be able to support the center and credited her and Philadelphia Police Commissioner Kevin Bethel's approach to addiction in the Kensington neighborhood of Philadelphia. Kensington has been at the forefront of the opioid crisis, garnering international attention for its open-air drug market in recent years. 'You need to crack down on the law and lawlessness and disorder in Kensington,' McCormick said. 'The mayor has done that.' During Parker's successful bid to become Philadelphia's 100th mayor in 2023, a key focus of her campaign was addressing the issue of drug abuse and quality of life in the Kensington neighborhood. Parker said she would end the open-air drug market for good and stabilize the neighborhood throughout her bid for office, the Philadelphia Inquirer reported. 'I think she's off to a great start on this,' he added. 'But you can't just treat … this problem narrowly. You have to have addiction recovery, which is what this program is meant to support.' The U.S. House narrowly passed a budget reconciliation package on May 22, which President Donald Trump dubbed the 'Big, Beautiful Bill.' The 1,116-page omnibus, combining 11 bills and many of Trump's policy goals, is now being reworked in the U.S. Senate. McCormick, an ally of Trump, described it as a 'good start,' but said he believes the spending package needs more work. Among the things the bill gets right, McCormick listed the permanent renewal of Trump's first term tax cuts and eliminating tax on tips, Social Security and overtime. He applauded the bill's increased funding of border security, border patrol, and national defense. McCormick also highlighted the efforts in the package to 'bend the curve on costs.' 'Some of these programs are spiraling out of control,' McCormick said. 'Medicaid is the one that has all the controversy.' 'It doesn't cut Medicaid spending. It slows the growth from 5% a year to 3% a year,' he said. 'And it does that by taking people out of the program, particularly working age men without dependents, takes them out of the program, [which] was never designed for them.' The nonpartisan Congressional Budget Office estimates the House version of the bill would lead to 10.9 million more people being uninsured in 2034, with 7.8 million of those due to the bill's Medicaid changes and the rest due to changes in the Affordable Care Act, according to McCormick said the government needs to reduce spending, saying the current spending rate is 'not sustainable.' Some adjustments he'd like to see included a phasing out of a number of subsidies and tax credits, instead of an immediate ending. 'I think those should be phased out in a way that's not too disruptive to some of the investment in projects that's already been made,' McCormick said. He also made the case the Senate should add a proposal that would add $10 billion towards school vouchers. Trump broke the news last month that a $14 billion merger deal between Pittsburgh-based U.S. Steel and Japan's Nippon Steel was nearing a conclusion after 18 months in limbo. Details of the tie-up remain secret and company officials have declined comment. Bloomberg News on Thursday cited sources close to the talks who spoke on condition of anonymity because they're confidential who said the deal is on track to meet a June 18 deadline. McCormick said he's 'very optimistic' that the deal, for which Trump took credit, will ultimately benefit western Pennsylvania's Monongahela Valley, where U.S. Steel operates three plants. 'It's $14 billion of investment in the domestic steel industry, $2.4 billion in the Mon Valley,' McCormick said on Friday. 'It guarantees and protects 10,000 jobs in the Mon Valley, but it also promises a new arc furnace, which is going to create 14,000 new jobs building that furnace.' McCormick also touted that in addition to remaining Pittsburgh-based, U.S. Steel will have a CEO and majority board from the United States, while the government would have control over the appointments of 'a couple key board members.' McCormick argues that this will 'protect U.S. interest.' McCormick also acknowledged that Trump previously 'had some real reservations' about the deal before the latest adjustments were made, but said the current deal 'supports working people' in that region. 'My first encounter with these steel workers was in Latrobe at a rally for the president, and they're out there. They wanted the deal because it protects their livelihoods,' McCormick said. USW International President David McCall said last week that the union still had concerns about the effects the proposed merger would have on national security, its members and the communities where they work. However, McCormick said he doesn't share those concerns. 'I'm focused on the steel workers in Pennsylvania — 4,000 of them in the Mon Valley. They're all in,' McCormick said. 'You watch that rally when President Trump came. Those are all steel workers going crazy.' 'This is great for Pennsylvania. It's great for the Mon Valley,' he added. 'It's great for domestic steel production. It's great for national security. I feel very confident in that.'
Yahoo
13 hours ago
- Yahoo
Is UnitedHealth a Millionaire Maker?
The stock's sharp decline, past returns, and competitive advantages make it a tempting buy-the-dip stock idea. Investors should exercise caution when basing their opinions on the past, given the numerous issues that have come to light. UnitedHealth's numerous headaches and massive size signal a difficult path forward for investors seeking life-changing investment returns. 10 stocks we like better than UnitedHealth Group › There is a ton of money in America's healthcare system. The country's annual healthcare expenditures push $5 trillion, representing nearly a fifth of the world's largest economy. UnitedHealth (NYSE: UNH) has generated life-changing returns as one of the industry's most powerful companies. At its peak in late 2024, the stock had returned over 60,000% since 1990. That turns each invested dollar into over $600. But as you may know, the company and stock have plunged into uncertainty after the high-profile slaying of the CEO of the company's insurance and managed care arm, UnitedHealthcare, in December, and numerous setbacks since then, some potentially criminal. It's a conundrum for investors deciding whether UnitedHealth can replicate its past success once the dust settles, or if this is a broken business to avoid. I looked under the hood to gauge whether UnitedHealth can still make investors rich. UnitedHealth operates the largest health insurer in the United States, UnitedHealthcare. While the stock has shed over half its value since the tragic death of UnitedHealthcare's CEO, the parent company's troubles stretch far beyond. Patients enrolled in UnitedHealth's Medicare Advantage plans are seeking more care than UnitedHealth had forecasted, unexpectedly raising costs. Management revised its 2025 guidance in first-quarter earnings in April, then withdrew guidance altogether in May after these trends continued. Additionally, UnitedHealth is facing some serious allegations of unethical business practices. Reports emerged that the U.S. Department of Justice is investigating the company for possible Medicare fraud. Another report alleged that UnitedHealth secretly paid care facilities to deny hospital transfers and other services to patients it covered. It creates a complicated situation for investors, who must try to piece together answers for questions like: Are there any other allegations, investigations, or other controversies that aren't public yet? Is the company guilty of these existing allegations? If so, how much can investors trust the company's past business performance? The logical investment thesis for UnitedHealth is that it remains one of the most powerful players in a multitrillion-dollar healthcare system. It boasts unmatched size, with over $410 billion in annual revenue, and owns multiple components of the healthcare system. For example, it serves as both an insurer and a pharmacy benefits manager (PBM), affording it tremendous leverage over suppliers, providers, and patients. UnitedHealth could face substantial fines, and some employees may even face imprisonment if investigations find that criminal activity occurred in the company's dealings. However, barring the government stepping in and forcing UnitedHealth to break apart, its core competitive advantages (size and vertical integration) are likely to remain intact. Approaching with caution is wise in such a situation where it's unclear to what degree, or for how long, all of UnitedHealth's issues may impact the business and stock. Analysts have dramatically lowered their long-term growth expectations, while the sliding share price has dropped the price-to-earnings ratio to under 13. At the moment, it's hard to envision UnitedHealth returning to business as usual anytime soon. Even if all the controversy goes away overnight, its medical costs are still surging. If UnitedHealth grows its earnings at a 7% annualized rate going forward, the stock's current P/E ratio appears to be a solid value, assuming no serious outcomes from any investigations or allegations. But even if UnitedHealth returns to form, it remains a behemoth of a company with over $400 billion in annual revenue. It will be much harder to generate enough growth from its current size to turn any realistic sum for most individual investors into a fortune. Given the entire picture here, it becomes increasingly clear that UnitedHealth's millionaire-making years are likely in the past. Before you buy stock in UnitedHealth Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and UnitedHealth Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $668,538!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $869,841!* Now, it's worth noting Stock Advisor's total average return is 789% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Justin Pope has no position in any of the stocks mentioned. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy. Is UnitedHealth a Millionaire Maker? was originally published by The Motley Fool
Yahoo
18 hours ago
- Yahoo
Luigi Mangione had diary where he wrote about plans to kill UnitedHealthcare CEO
The Brief Court documents are shedding new light on the murder of United Healthcare CEO Brian Thompson. New York state prosecutors say Luigi Mangione had a diary where he wrote about his plans to kill the healthcare executive, months before he was gunned down in New York City. In Wednesday's 82-page filing, prosecutors justified adding terrorism to Mangione's first-degree murder charge. NEW YORK (FOX 9) - Prosecutors say, to Mangione, Thompson and UnitedHealthcare were symbols of the healthcare industry and what the 27-year-old considered a deadly greed-fueled cartel. What we know When Luigi Mangione was arrested by police in Altoona, Pennsylvania, last December, prosecutors say they recovered a red notebook he used as a diary among his possessions. They say the diary includes several entries that explain Mangione's intent and motive to deliberately assassinate Brian Thompson, the CEO of United Healthcare, the country's largest health insurance company. The backstory Prosecutors say an entry in August 2024 reads, "I finally feel confident about what I will do. The details are coming together. And I don't feel any doubt about whether its right/justified." He goes on to write, "The target is insurance. It checks every box." Then, in October of last year, about a month and a half before Thompson was shot and killed outside the midtown Manhattan hotel where United Healthcare's annual investors conference was scheduled to be held, Mangione writes: "The investor conference is a true windfall. It embodies everything wrong with our health system, and - most importantly -- the message becomes self-evident." Prosecutors say Mangione references Ted Kaczynski, saying the Unabomber made some good points, but he crossed the line from anarchist to terrorist by indiscriminately mail bombing innocent people. In his diary, prosecutors say Mangione writes "...instead of carrying out a bombing, one should "wack" the CEO at the annual parasitic bean counter convention. It's targeted, precise and doesn't risk innocents." "The point is made in the news headline 'Insurance CEO killed at annual investors conference.'" What they're saying In the filing, prosecutors wrote, "If ever there were an open and shut case pointing to defendant's guilt, this case is that case. Simply put, one would be hard-pressed to find a case with such overwhelming evidence of guilt as to the identity of the murderer and the premeditated nature of the assassination."